COMMUNIQUÉS West-GlobeNewswire

First Patient Dosed in Phase 2 Study of PARP/Tankyrase Inhibitor 2X-121 for Metastatic Breast Cancer

26/06/2018 - 15:15

CAMBRIDGE, Mass. and HOERSHOLM, Denmark, June 26, 2018 (GLOBE NEWSWIRE) -- Oncology Venture US Inc., Oncology Venture AB (OV:ST) (“OV”) and Medical Prognosis Institute A/S (MPI:ST) today announced dosing of the first [...]

Admera Health Announces Availability of Psychiatric Specific Report, PGxPsych™, for its PGxOne™ Plus Pharmacogenomics Test

26/06/2018 - 15:13

SOUTH PLAINFIELD, N.J., June 26, 2018 (GLOBE NEWSWIRE) -- Today, Admera Health ( www.admerahealth.com ), announced the availability of a psychiatric specific report for its PGxOne™ Plus pharmacogenomics test. PGxOne™ [...]

WellDoc® Presents Results of an Innovative Economic Analysis Demonstrating Opportunity for Significant Healthcare Cost Savings with the Use of BlueStar®

26/06/2018 - 15:03

Findings Shared During Poster Presentation at the American Diabetes Association’s (ADA) 78th Scientific Sessions BALTIMORE, Md., June 26, 2018 (GLOBE NEWSWIRE) -- WellDoc®, a leading digital health company [...]

Arch Biopartners Receives $332,750 From the Exercise of Warrants

26/06/2018 - 15:03

TORONTO, June 26, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners, Inc., (Arch or the Company) (TSX-V:ARCH) (OTCQB:ACHFF) a portfolio-based biotechnology company, today announced that it received net proceeds of $332,750 [...]

Photocure ASA: Kjetil Hestdal steps down as CEO

26/06/2018 - 15:02

Oslo, Norway, 26 June 2018: Photocure ASA (OSE: PHO), announces today that President and Chief Executive Officer, Kjetil Hestdal, will step down effective 1 July 2018 as the company is entering a new growth phase with [...]

NSS Labs Chosen as a 2018 Red Herring Top 100 North America Winner

26/06/2018 - 15:00

Company Earns Prestigious Honor for Second Consecutive Year and Advances Mission to Empower Enterprises to Know Where they Stand AUSTIN, Texas, June 26, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and [...]

Keeping Your Vagina Clean, Comfortable, and Happy, with the Newly Designed Patented Smooth Applicator

26/06/2018 - 15:00

Introducing the pHemme® family of products specifically design for the modern women to tackle on today’s feminine hygiene issues. TORONTO, June 26, 2018 (GLOBE NEWSWIRE) -- Not everyone has symptoms when they’ve [...]

Gardez votre vagin propre, confortable et heureux avec l’applicateur lisse redessiné et breveté

26/06/2018 - 15:00

Voici la gamme de produits pHemme® à l’intention de la femme moderne, conçue pour parer aux problèmes d’hygiène féminine d’aujourd’hui. TORONTO, 26 juin 2018 (GLOBE NEWSWIRE) -- Ce ne sont pas toutes les femmes qui [...]

BLVD Centers Begins Trading on Canadian Securities Exchange; Voluntarily Delists From TSX Venture Exchange

26/06/2018 - 15:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LOS ANGELES, June 26, 2018 (GLOBE NEWSWIRE) -- BLVD Centers Corporation (“ BLVD ” or the “ Company ”) (CSE:BLVD), in [...]

Valens GroWorks Laser Focused on Quality Control Throughout Supply Chain -- CFN Media

26/06/2018 - 15:00

SEATTLE, June 26, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]

Sapience Therapeutics, Inc. Selected as a Winner of the JLABS NYC QuickFire Challenge

26/06/2018 - 14:59

HARRISON, N.Y., June 26, 2018 (GLOBE NEWSWIRE) -- Sapience Therapeutics, Inc., a biotechnology company focused on developing peptide therapeutics to address difficult to treat oncology indications, announced today that [...]

VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market

26/06/2018 - 14:57

TEL AVIV, Israel, June 26, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Lexaria's DehydraTECH Overcomes Key Hurdles for Cannabis Extracts -- CFN Media

26/06/2018 - 14:50

SEATTLE, June 26, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]

ICC Labs Receives Additional Land From the Government of Uruguay to Increase Its Production Capacity at Its Psychoactive Facility

26/06/2018 - 14:48

VANCOUVER, British Columbia, June 26, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V:ICC) (Frankfurt:2Q9) is pleased to announce that the Government of Uruguay through its regulatory [...]

Devonian Health Group announces the commercial launch of the Purgenesis(TM) Anti-aging treatment at the Canadian Dermatology Association’s annual conference

26/06/2018 - 14:45

First launch of the Purgenesis™ skin care line First and only product line distributed by dermatologists with the seal of the Canadian Dermatology Association’s Skin Health Program™ QUEBEC CITY, June 26, 2018 (GLOBE [...]

Groupe Santé Devonian annonce le lancement commercial du traitement anti-âge Purgenesis(MC) à la conférence annuelle de l’Association canadienne de dermatologie

26/06/2018 - 14:45

Premier lancement de la gamme de produits de soin de la peau Purgenesis MC La première et l’unique gamme de produits distribuée par les dermatologues portant le seau du Programme de santé de la peau MC de l’Association [...]

UPDATE -- ZEMDRI™ (plazomicin) Approved by FDA for the Treatment of Adults with Complicated Urinary Tract Infections (cUTI)

26/06/2018 - 14:33

― ZEMDRI is a new treatment for patients with cUTI, including pyelonephritis, due to certain Enterobacteriaceae ― ― ZEMDRI is the only once-daily aminoglycoside therapy approved for use in cUTI ― ― ZEMDRI has [...]

Avinger Announces Successful Treatment of First Patients with Next-Generation Pantheris in Several Centers throughout the US

26/06/2018 - 14:30

REDWOOD CITY, Calif., June 26, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that several physicians have [...]

Progenics Pharmaceuticals Completes Enrollment of Phase 2/3 Clinical Trial of PSMA-Targeted PET/CT Imaging Agent PyL™ in Prostate Cancer

26/06/2018 - 14:30

Top-line Data Expected in 4Q2018 NEW YORK, June 26, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and imaging technology for targeting and [...]